Iradimed Corporation
(NASDAQ) IRMD
Iradimed Corporation Financials at a Glance
Market Cap
$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$86.28M
Net Income (TTM)
$23.61M
EPS (TTM)
$1.84
P/E Ratio
52.94
Dividend
$0.74
Beta (Volatility)
0.92 (Low)
Dividend
$0.74
Beta (Volatility)
0.92 (Low)
Price
$97.31
Volume
88,908
Open
$98.23
Price
$97.31
Volume
88,908
Open
$98.23
Previous Close
$97.20
Daily Range
$97.11 - $98.64
52-Week Range
$54.82 - $107.90
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.74
Beta (Volatility)
0.92 (Low)
Price
$97.31
Volume
88,908
Open
$98.23
Previous Close
$97.20
Daily Range
$97.11 - $98.64
52-Week Range
$54.82 - $107.90
Estimated Earnings Date
Jul 30, 2026
IRMD News
IRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Iradimed Corporation
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
166
CEO
Roger Susi
Website
www.iradimed.comHeadquarters
Winter Springs, FL 32708, US
IRMD Financials
Key Financial Metrics (TTM)
Gross Margin
76.84%
Operating Margin
32.40%
Net Income Margin
27.36%
Return on Equity
24.48%
Return on Capital
27.63%
Return on Assets
20.64%
Earnings Yield
1.89%
Dividend Yield
0.76%
Payout Ratio
65.37%
Stock Overview
Market Cap
$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
12.78M
Volume
88.91K
Avg. Volume
133.16K
Financials (TTM)
Gross Profit
$66.30M
Operating Income
$27.95M
EBITDA
$32.23M
Operating Cash Flow
$28.94M
Capital Expenditure
-$4.85M
Free Cash Flow
$24.10M
Cash & ST Invst.
$56.37M
Total Debt
$0.00
Iradimed Corporation Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.98M
+12.7%
Gross Profit
$16.81M
+13.3%
Gross Margin
76.50%
N/A
Market Cap
$1.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.77M
N/A
Employees
160
N/A
Net Income
$5.82M
+24.1%
EBITDA
$8.22M
+34.0%
Quarterly Fundamentals
Total Cash
$56.37M
+12.0%
Total Debt
$0.00
-100.0%
Accounts Receivable
$13.42M
+5.6%
Inventory
$11.88M
+12.6%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
20.64%
N/A
Return on Invested Capital
27.33%
N/A
Free Cash Flow
$7.89M
+1226.4%
Operating Cash Flow
$8.29M
+93.1%